InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Renninger Robert. Insider active across 2 companies, notably Athira Pharma, Inc.. Aggregated, 4 reports have been recorded. History available since 18 November 2024. The latest transaction was filed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Renninger Robert is linked to Athira Pharma, Inc. and LeonaBio, Inc. as Chief Financial Officer, respectively CHIEF FINANCIAL OFFICER. His 4 known filings run from 2025-01-03 to 2026-03-05, and the sampled recent filings show no buy or sell activity, with the dominant transaction nature indicated as Attribution.